• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管鳞状细胞癌患者根治性切除术后并发症的预后意义

Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.

作者信息

Saeki Hiroshi, Tsutsumi Satoshi, Tajiri Hirotada, Yukaya Takafumi, Tsutsumi Ryosuke, Nishimura Sho, Nakaji Yu, Kudou Kensuke, Akiyama Shingo, Kasagi Yuta, Nakanishi Ryota, Nakashima Yuichiro, Sugiyama Masahiko, Ohgaki Kippei, Sonoda Hideto, Oki Eiji, Maehara Yoshihiko

机构信息

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Ann Surg. 2017 Mar;265(3):527-533. doi: 10.1097/SLA.0000000000001692.

DOI:10.1097/SLA.0000000000001692
PMID:28169928
Abstract

OBJECTIVE

The objective of this study was to elucidate the impact of postoperative complications on long-term survival after curative resection for esophageal squamous cell carcinoma.

BACKGROUND

The relation between postoperative complications and long-term survival after curative surgery for esophageal squamous cell carcinoma is controversial; thus, this issue should be resolved with a large-scale, well-designed study.

METHODS

Clinicopathological features and survival of 580 consecutive patients who received curative resection for esophageal squamous cell carcinoma were investigated according to the development of postoperative pulmonary complications and anastomotic leakage.

RESULTS

The 5-year survival rates of patients with pStage 0, I, and II disease with postoperative complications (n = 116) were significantly poorer than those of patients without postoperative complications (n = 288) (overall 69.6% vs 46.9%, P < 0.0001; disease-specific; 76.7% vs 58.9%, P < 0.0022), whereas no differences were found in patients with pStage III and IV disease (n = 176). In the univariate and multivariate analyses for disease-specific survival, pT3, pT4, pN positivity, and development of postoperative complications were significant prognostic factors in all patients. Also, when the analysis was limited to the pStage 0, I, and II patients, development of postoperative complications, and pT3, pT4, and pN positivity, were found to be independent poor prognostic factors in multivariate analyses (hazard ratio: 1.56, 95% confidence interval, 1.01-2.41, P = 0.0476).

CONCLUSIONS

The development of postoperative complications is an independent disease-specific poor prognostic factor after curative resection for patients with less-advanced esophageal squamous cell carcinoma.

摘要

目的

本研究旨在阐明术后并发症对食管鳞状细胞癌根治性切除术后长期生存的影响。

背景

食管鳞状细胞癌根治性手术后,术后并发症与长期生存之间的关系存在争议;因此,这个问题应该通过大规模、精心设计的研究来解决。

方法

根据术后肺部并发症和吻合口漏的发生情况,对580例连续接受食管鳞状细胞癌根治性切除的患者的临床病理特征和生存情况进行了调查。

结果

术后出现并发症的pStage 0、I和II期疾病患者(n = 116)的5年生存率显著低于无术后并发症的患者(n = 288)(总体为69.6%对46.9%,P < 0.0001;疾病特异性为76.7%对58.9%,P < 0.0022),而pStage III和IV期疾病患者(n = 176)未发现差异。在疾病特异性生存的单因素和多因素分析中,pT3、pT4、pN阳性以及术后并发症的发生是所有患者的重要预后因素。此外,当分析仅限于pStage 0、I和II期患者时,术后并发症的发生以及pT3、pT4和pN阳性在多因素分析中被发现是独立的不良预后因素(风险比:1.56,95%置信区间,1.01 - 2.41,P = 0.0476)。

结论

对于进展期较低的食管鳞状细胞癌患者,术后并发症的发生是根治性切除术后独立的疾病特异性不良预后因素。

相似文献

1
Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌患者根治性切除术后并发症的预后意义
Ann Surg. 2017 Mar;265(3):527-533. doi: 10.1097/SLA.0000000000001692.
2
Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.对接受手术切除的食管鳞状细胞癌患者进行第7版TNM分类评估。
World J Gastroenterol. 2014 Dec 28;20(48):18397-403. doi: 10.3748/wjg.v20.i48.18397.
3
The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.神经周围侵犯状态可预测局部晚期食管鳞状细胞癌术后放疗的疗效。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6881-90. eCollection 2015.
4
Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.食管鳞癌患者术后早期复发和死亡。
Ann Thorac Surg. 2011 May;91(5):1502-8. doi: 10.1016/j.athoracsur.2011.01.007. Epub 2011 Feb 26.
5
Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.食管鳞状细胞癌合并多原发癌行根治性手术切除的安全性及获益情况。
Eur J Surg Oncol. 2016 Mar;42(3):407-11. doi: 10.1016/j.ejso.2015.11.012. Epub 2015 Dec 10.
6
Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.根治性放化疗后残留或复发食管鳞状细胞癌挽救性食管切除术的预后因素
World J Surg. 2018 Sep;42(9):2887-2893. doi: 10.1007/s00268-018-4536-7.
7
Prognostic Impact of Postoperative Complications in 502 Patients With Surgically Resected Esophageal Squamous Cell Carcinoma: A Retrospective Single-institution Study.502例手术切除食管鳞状细胞癌患者术后并发症的预后影响:一项单机构回顾性研究
Ann Surg. 2016 Aug;264(2):305-11. doi: 10.1097/SLA.0000000000001510.
8
Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas.内镜切除治疗表浅性食管鳞状细胞癌的疗效标准。
Dig Dis Sci. 2018 Jun;63(6):1605-1612. doi: 10.1007/s10620-018-5029-0. Epub 2018 Mar 21.
9
Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.伴有非区域淋巴结转移的食管癌切除术后长期生存的预测因素。
Ann Thorac Surg. 2009 Jul;88(1):186-92; discussion 192-3. doi: 10.1016/j.athoracsur.2009.03.079.
10
Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.根治性切除术后胸段食管鳞癌淋巴结复发患者的治疗效果和预后。
World J Surg. 2011 Apr;35(4):798-804. doi: 10.1007/s00268-011-0978-x.

引用本文的文献

1
Comprehensive risk score of the E-PASS scoring system serves a prognostic indicator for patients after neoadjuvant therapy and curative esophageal cancer surgery: a multicenter retrospective study.E-PASS评分系统的综合风险评分可作为新辅助治疗后及食管癌根治性手术后患者的预后指标:一项多中心回顾性研究
Front Oncol. 2025 Jun 6;15:1617683. doi: 10.3389/fonc.2025.1617683. eCollection 2025.
2
Current Status and Future Applications of Robotic Surgery in Upper Gastrointestinal Surgery: A Narrative Review.机器人手术在上消化道手术中的现状与未来应用:一项叙述性综述
Cancers (Basel). 2025 Jun 10;17(12):1933. doi: 10.3390/cancers17121933.
3
Pulmonary infection after esophageal cancer surgery: impact on the reality, risk factors and development of a predictive nomogram.
食管癌手术后肺部感染:对实际情况的影响、危险因素及预测列线图的构建
World J Surg Oncol. 2025 Apr 21;23(1):149. doi: 10.1186/s12957-025-03806-1.
4
The impact of perioperative oral care on postoperative infection in patients with esophageal cancer: a retrospective cohort study before and during COVID-19.围手术期口腔护理对食管癌患者术后感染的影响:一项COVID-19疫情之前及期间的回顾性队列研究
Surg Today. 2025 Mar 14. doi: 10.1007/s00595-025-03025-x.
5
Morphomic predictors for post-esophagectomy pulmonary complications and overall survival.食管切除术后肺部并发症和总生存期的形态学预测指标
J Thorac Dis. 2025 Jan 24;17(1):209-219. doi: 10.21037/jtd-24-1227. Epub 2025 Jan 22.
6
Essential updates 2022/2023: Recent advances in perioperative management of esophagectomy to improve operative outcomes.2022/2023年重要更新:食管癌切除术围手术期管理的最新进展以改善手术效果。
Ann Gastroenterol Surg. 2024 Jul 29;8(6):966-976. doi: 10.1002/ags3.12847. eCollection 2024 Nov.
7
The seven-day cumulative post-esophagectomy inflammatory response predicts cancer recurrence.术后七天累积炎症反应预测癌症复发。
BMC Surg. 2024 Oct 5;24(1):289. doi: 10.1186/s12893-024-02563-4.
8
Effect of Perioperative Inhaled Tiotropium for patients with chronic Obstructive Pulmonary disease in Esophageal cancer surgery (EPITOPE): an open-label, randomized, parallel-group pilot study.围手术期吸入噻托溴铵对食管癌手术合并慢性阻塞性肺疾病患者的影响(EPITOPE):一项开放标签、随机、平行组试点研究。
Gen Thorac Cardiovasc Surg. 2025 Jan;73(1):58-65. doi: 10.1007/s11748-024-02083-1. Epub 2024 Sep 18.
9
Effect of surgical complications on outcomes of children with hepatoblastoma: a retrospective cohort study.手术并发症对肝母细胞瘤患儿预后的影响:一项回顾性队列研究。
Surg Today. 2025 Feb;55(2):197-204. doi: 10.1007/s00595-024-02906-x. Epub 2024 Aug 16.
10
Usefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study.围手术期应用谷氨酰胺/精氨酸/钙 β-羟基-β-甲基丁酸盐产品对食管癌手术的作用:一项单中心回顾性研究。
Nutrients. 2024 Jul 3;16(13):2126. doi: 10.3390/nu16132126.